Literature DB >> 11082428

Regulation of the human norepinephrine transporter by cocaine and amphetamine.

M Y Zhu1, S Shamburger, J Li, G A Ordway.   

Abstract

Certain antidepressant and psychostimulant drugs block the uptake of norepinephrine from the synaptic cleft by inhibiting norepinephrine transporter (NET) function. The effects of chronic occupation of the NET by these drugs on NET expression are poorly understood. We previously described down-regulation of the NET in cultured cells after continuous exposure to the tricyclic antidepressant desipramine. Here, the effects of structurally unrelated NET ligands, cocaine and amphetamine, on levels of NET and on NET function in HEK-293 cells transfected with human NET cDNA were investigated. All drug exposures were followed by incubation in drug-free media before harvesting and assays. Exposure of intact cells to cocaine for 3 days did not significantly affect the B(max) or K(D) of [(3)H]nisoxetine binding to NET in membrane homogenates, and did not alter levels of NET immunoreactivity or NET mRNA. In contrast, incubation of cells with amphetamine significantly reduced [(3)H]nisoxetine binding to NET and levels of NET immunoreactivity in a time-dependent manner, although levels of NET mRNA appeared to be unaffected. Exposures to cocaine or amphetamine resulted in significant reductions of [(3)H]norepinephrine uptake, although the magnitude of the reduction produced by amphetamine was much greater than cocaine. [(3)H]Nisoxetine binding to NET and NET protein levels were also reduced by exposure of cells to high concentrations of norepinephrine, although norepinephrine exposures were accompanied by changes indicative of cellular toxicity. Cocaine and amphetamine have distinctly different effects on NET expression after continuous exposure. The ability of only certain drugs to down-regulate the NET may provide clues to the unique therapeutic effects of antidepressants that are NET ligands.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082428

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner.

Authors:  Michael W Quick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.

Authors:  Balasubramaniam Annamalai; Padmanabhan Mannangatti; Obulakshmi Arapulisamy; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  J Neurochem       Date:  2010-07-30       Impact factor: 5.372

3.  Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain.

Authors:  Thomas J R Beveridge; Hilary R Smith; Michael A Nader; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

4.  Functional connectivity during language processing in acute cocaine withdrawal: a pilot study.

Authors:  Ananth Narayanan; Catherine A White; Sanjida S Saklayen; Amir Abduljalil; Petra Schmalbrock; Tom H Pepper; Brad N Lander; David Q Beversdorf
Journal:  Neurocase       Date:  2011-11-14       Impact factor: 0.881

Review 5.  Regulation of monoamine transporters: Role of transporter phosphorylation.

Authors:  Sammanda Ramamoorthy; Toni S Shippenberg; Lankupalle D Jayanthi
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

6.  The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.

Authors:  Meng-Yang Zhu; Patrick B Kyle; Arthur S Hume; Gregory A Ordway
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

7.  Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourse.

Authors:  Hank P Jedema; Rajesh Narendran; Charles W Bradberry
Journal:  J Neurochem       Date:  2014-05-19       Impact factor: 5.372

8.  Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference.

Authors:  Padmanabhan Mannangatti; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  Neuropharmacology       Date:  2017-10-04       Impact factor: 5.250

Review 9.  A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.

Authors:  S D Robertson; H J G Matthies; A Galli
Journal:  Mol Neurobiol       Date:  2009-02-06       Impact factor: 5.590

10.  Cerebrospinal Fluid Norepinephrine and Neurocognition in HIV and Methamphetamine Dependence.

Authors:  Rowan Saloner; Mariana Cherner; Jennifer E Iudicello; Robert K Heaton; Scott L Letendre; Ronald J Ellis
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.